SCHEMBL7350466

SCHEMBL7350466

N[C@H]1CCCCN(CCC(=O)O)C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 4/20 0.39
TDP1 Q9NUW8 2/20 0.38
MAPT P10636 2/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
APEX1 P27695 1/20 0.38
DPP4 P27487 1/20 0.38
MAPK1 P28482 2/20 0.36
CYP1A2 P05177 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALOX15 P16050 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
LTA4H P09960 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11255094 1.00 ACE (0.39) ACETDP1MAPTTSHRCYP3A4
SCHEMBL11280204 0.98 MAPK1 (0.39) ACETDP1MAPTTSHRCYP3A4
Hydrochloric Acid SCHEMBL11261206 0.98 ACE (0.38) ACETDP1MAPTTSHRCYP3A4
SCHEMBL11264281 0.98 MAPK1 (0.39) ACETDP1MAPTTSHRCYP3A4
SCHEMBL6560268 0.88 TDP1 (0.46) ACETDP1MAPTTSHRCYP3A4
SCHEMBL6560275 0.88 TDP1 (0.46) ACETDP1MAPTTSHRCYP3A4
SCHEMBL6560272 0.88 TDP1 (0.46) ACETDP1MAPTTSHRCYP3A4
SCHEMBL28777585 0.84 ACE (0.40) ACETDP1MAPTTSHRCYP3A4
SCHEMBL197944 0.83 ACE (0.55) ACETDP1MAPTTSHRCYP3A4
SCHEMBL5639706 0.83 ACE (0.55) ACETDP1MAPTTSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5859239-A Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepines and benzothiazepines E. R. SQUIBB & SONS, INC. (US) 1999-01-12 US disclosed
US-5856477-A HYPOTENSIVE AGENTS; CONGESTIVE HEART FAILURE E. R. SQUIBB & SONS, INC. (US) 1999-01-05 US disclosed
CN-1039008-C Dual action inhibitors SQUIBB & SONS INC (US) 1998-07-08 CN disclosed
US-5723602-A ANGIOTENSIN CONVERTING ENZYME AND ENDOPEPTIDASE INHIBITORS, CARDIOVASCULAR DISORDERS E. R. SQUIBB & SONS, INC. (US) 1998-03-03 US disclosed
US-5723457-A COMPOUMDS FOR CARDIOVASCULAR DISORDERS AND INHIBITORS OF ANGIOTENSIN CONVERTING ENZYMES E. R. SQUIBB & SONS, INC. (US) 1998-03-03 US disclosed
EP-0599444-B1 Dual action inhibitors SQUIBB & SONS INC (US) 1998-01-28 EP disclosed
US-5654294-A CARDIOVASCULAR DISORDERS BRISTOL-MYERS SQUIBB (US) 1997-08-05 US disclosed
US-5646276-A ANGIOTENSIN CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE INHIBITORS; CARDIOVASCULAR DISORDERS BRISTOL-MYERS SQUIBB CO. (US) 1997-07-08 US disclosed
US-5552397-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1996-09-03 US disclosed
CN-1084849-A Dual action inhibitors SQUIBB & SONS INC (US) 1994-04-06 CN disclosed
EP-0046291-A2 Substituted caprolactam derivatives as antihypertensives, process for preparing them, pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP disclosed